Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6368 USD | -6.35% | +4.04% | -39.92% |
May. 20 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 20 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 1.2M | Sales 2025 * | 12.51M | Capitalization | 4.83M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -8M | EV / Sales 2024 * | 4.03 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.39 x |
P/E ratio 2024 * |
-0.42
x | P/E ratio 2025 * |
-0.74
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.7% |
Latest transcript on Ensysce Biosciences, Inc.
1 day | -6.35% | ||
1 week | +4.04% | ||
Current month | +7.64% | ||
1 month | +17.71% | ||
3 months | -28.85% | ||
6 months | -26.97% | ||
Current year | -39.92% |
Managers | Title | Age | Since |
---|---|---|---|
D. Kirkpatrick
CEO | Chief Executive Officer | 67 | 08-12-31 |
David Humphrey
DFI | Director of Finance/CFO | 55 | 21-01-31 |
Jeffrey Millard
COO | Chief Operating Officer | 49 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Martin
BRD | Director/Board Member | 63 | 19-12-31 |
D. Kirkpatrick
CEO | Chief Executive Officer | 67 | 08-12-31 |
Bob Gower
CHM | Chairman | 86 | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 0.6368 | -6.35% | 107,448 |
24-05-21 | 0.68 | -7.98% | 159,317 |
24-05-20 | 0.739 | +18.43% | 803,815 |
24-05-17 | 0.624 | -0.95% | 132,059 |
24-05-16 | 0.63 | +2.92% | 241,918 |
Delayed Quote Nasdaq, May 22, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.92% | 4.83M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.38% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- ENSC Stock